World Health Energy Holdings Inc (WHEN) Stock Analysis
Verdict: AVOID
Terminal financial distress and triple-digit negative margins suggest this sub-penny stock is essentially a non-viable shell company.
Investment score: 2/100
Analysis as of
Is World Health Energy Holdings Inc stock worth reviewing? The TradeMates thesis
The TradeMates model classifies WHEN as a high-risk micro-cap in terminal decline. With a net loss of $4.69M on just $166k in revenue and a debt-to-equity ratio of 2.25, the company faces immediate liquidity risks. The stock price of $0.000001 represents the bottom of the OTC range, offering no margin of safety.
7-factor investment score
- Valuation: 5/100 (weight 20%)
- Financial Health: 0/100 (weight 15%)
- Technical Momentum: 0/100 (weight 15%)
- Earnings Quality: 2/100 (weight 15%)
- Insider Sentiment: 10/100 (weight 10%)
- Analyst Consensus: 0/100 (weight 10%)
- Risk-Adjusted Return: 0/100 (weight 15%)
World Health Energy Holdings Inc opportunities and risks
What speaks for WHEN
- Parental Monitoring Niche
What speaks against WHEN
- Immediate Insolvency Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| WHEN | n/a | 249.6x | 22.9x | -42.6% | -1720.7% | -1735.5% |
| BKYI | n/a | 0.5x | n/a | 77.8% | -60.6% | -150.9% |
| IVDA | n/a | 0.2x | 1.5x | 27.9% | -55.4% | -249.4% |
| RDAR | n/a | 0.0x | 8.7x | 15.6% | -28.0% | -992.0% |
| UTRX | n/a | 2.4x | n/a | 0.0% | -18.7% | 5.3% |
| Peer median | n/a | 0.3x | 0.6x | 21.8% | -41.7% | -200.2% |
Frequently asked questions about World Health Energy Holdings Inc (WHEN)
Is WHEN stock a good investment?
The TradeMates model rates World Health Energy Holdings Inc as AVOID with an investment score of 2/100. The TradeMates model classifies WHEN as a high-risk micro-cap in terminal decline. With a net loss of $4.69M on just $166k in revenue and a debt-to-equity ratio of 2.25, the company faces immediate liquidity risks. The stock price of $0.000001 represents the bottom of the OTC range, offering no margin of safety. This is algorithmic model output, not personal investment advice.
Is WHEN stock a buy?
The TradeMates model verdict for WHEN is AVOID with an investment score of 2/100. Treat this as a model signal to review, not a personal buy recommendation.